EUVIMEDEUVIMED entdecken
Fallbericht

An ALK Immunohistochemical Pitfall: ALK -Positive Histiocytosis Versus Angiomatoid Fibrous Histiocytoma

Justin Chang, Anna C Greenwood, Chelsea Kidd, Julio A Diaz-Perez iD, Steven Christopher Smith iD

International Journal of Surgical Pathology · 2025

DOI: 10.1177/10668969241308201 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Surgical Pathology, 2025. Verfasst von Justin Chang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, VCU School of Medicine, Richmond, VA, USA. Hauptthemen laut MEDLINE: Anaplastic Lymphoma Kinase, Biomarkers, Tumor, Histiocytoma, Malignant Fibrous, Histiocytosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The proliferation of recognized neoplasms related to related to rearrangements involving kinase genes, arising in diverse somatic tissue lineages, poses an increasing challenge in surgical pathology. For instance, ALK rearrangements have been observed in diverse neoplasms of epithelial, connective tissue, and hematolymphoid lineages, many of which are associated with overexpression of ALK by immunohistochemistry as a useful biomarker. An even higher order challenge and pitfall would be the scenario where a tumor without an ALK rearrangement nonetheless overexpresses the protein, thereby simulating an ALK-defined neoplasm. Herein, we present this exact scenario, where an angiomatoid fibrous histiocytoma, exhibiting the recently-described phenomenon of its overexpression of ALK, clinically, histologically, and immunophenotypically simulated ALK-positive histiocytosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anaplastic Lymphoma KinaseBiomarkers, TumorHistiocytoma, Malignant FibrousHistiocytosisHumansMaleDiagnosis, DifferentialGene RearrangementImmunohistochemistryChild

Stichwörter der Autor:innen

ALKALK-positive histiocytosisangiomatoid fibrous histiocytoma

Substanzen

ALK protein, humanAnaplastic Lymphoma KinaseBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, VCU School of Medicine, Richmond, VA, USA.
  • Department of Orthopaedic Surgery, VCU School of Medicine, Richmond, VA, USA.
  • Department of Surgery, VCU School of Medicine; Department of Pathology, Richmond Veterans Affairs Medical Center; and VCU Massey Comprehensive Cancer Center, Richmond, VA, USA.

ORCID-Profile: Julio A Diaz-Perez, Steven Christopher Smith

Zitieren

APA

Chang, J., Greenwood, A. C., Kidd, C., Diaz-Perez, J. A., & Smith, S. C. (2025). An ALK Immunohistochemical Pitfall: ALK -Positive Histiocytosis Versus Angiomatoid Fibrous Histiocytoma. International Journal of Surgical Pathology. https://doi.org/10.1177/10668969241308201

Vancouver

Chang J, Greenwood AC, Kidd C, Diaz-Perez JA, Smith SC. An ALK Immunohistochemical Pitfall: ALK -Positive Histiocytosis Versus Angiomatoid Fibrous Histiocytoma. International Journal of Surgical Pathology. 2025. doi:10.1177/10668969241308201

BibTeX
@article{Chang2025,
  author = {Chang, Justin and Greenwood, Anna C and Kidd, Chelsea and Diaz-Perez, Julio A and Smith, Steven Christopher},
  title = {An ALK Immunohistochemical Pitfall: ALK -Positive Histiocytosis Versus Angiomatoid Fibrous Histiocytoma},
  journal = {International Journal of Surgical Pathology},
  year = {2025},
  doi = {10.1177/10668969241308201}
}
Kostenlos starten →